Table 1.
Baseline Demographics and Disease Characteristics
| Parameter | n=175 |
|---|---|
| Gender, n (%) | |
| Male | 98 (56) |
| Female | 77 (44) |
| Age (years), mean (SD) | 44.7 (20.7) |
| AD family history, n (%) | 75 (42.9) |
| Atopic comorbidities, n (%) | 80 (47.5) |
| Phenotypes, n (%) | |
| Classic AD | 159 (91) |
| Prurigo Nodularis-like | 16 (9) |
| EASI, median (min-max) | 26 (24–49) |
| VAS pruritus, median (min-max) | 8 (0–10) |
| Total serum IgE (kU/L), median (min-max) | 743 (1.4–22,085) |
| Blood Eosinophils count (x103/uL), median (min-max) | 0.35 (0–2.30) |
| Serum LDH (mU/mL), median (min-max) | 201 (121–497) |
| Previous systemic treatment, n (%) | |
| Antihistamines | 132 (75.4) |
| Corticosteroids | 30.3 (53) |
| Cyclosporine A | 133 (76) |
| Phototherapy | 80 (45.7) |
Abbreviations: SD, standard deviation; AD, atopic dermatitis; EASI, eczema area and severity index; VAS, visual analogue scale; IgE, immunoglobulin E; LDH, lactate dehydrogenase.